Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis | eLife
The Diagnostic Utility of Cancer Stem Cell Marker CD44 in Early Detection of Oral Cancer
Elevated CD44 expression predicts poor prognosis in patients with low‑grade glioma
Frontiers | Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients
CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma | Cancer Cell International | Full Text
![PDF] Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dc57f20a8d785a8c01135abe61fb851d38553ac8/4-Figure1-1.png "PDF] Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity | Semantic Scholar")
PDF] Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity | Semantic Scholar
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases | PLOS ONE
Cancers | Free Full-Text | Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
Cureus | Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy
Cervical cancer stem cell‑associated genes: Prognostic implications in cervical cancer (Review)
CD44v6 engages in colorectal cancer progression | Cell Death & Disease
Biomolecules | Free Full-Text | CD44: A Multifunctional Mediator of Cancer Progression
Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis | eLife
![PDF] Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9a92b7ef54df06d7ea844dcb3489b284da252e49/5-Figure1-1.png "PDF] Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer | Semantic Scholar")
PDF] Breast cancer stem cell markers CD44 and ALDH1A1 in serum: distribution and prognostic value in patients with primary breast cancer | Semantic Scholar
CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation | Oncotarget
CD44 -- A New Prognostic Marker for Neuroblastoma | NEJM
Frontiers | Abnormal Glycosylation of Cancer Stem Cells and Targeting Strategies
Receptor‐Targeted Drug Delivery and the (Many) Problems We Know of: The Case of CD44 and Hyaluronic Acid - Rios de la Rosa - 2018 - Advanced Biosystems - Wiley Online Library
Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases | PLOS ONE
Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” - eBioMedicine
CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours - eBioMedicine
Frontiers | Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis - ScienceDirect
CD44 as a cancer stem cell marker in various cancer types | Download Table
The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases | Anticancer Research
